Maria L. Stewart

Concentrated oat β-glucan, a fermentable fiber, lowers serum cholesterol in hypercholesterolemic adults in a randomized controlled trial

BackgroundSoluble fibers lower serum lipids, but are difficult to incorporate into products acceptable to consumers. We investigated the physiological effects of a concentrated oat β-glucan on cardiovascular disease (CVD) endpoints in human subjects. We also compared the fermentability of concentrated oat β-glucan with inulin and guar gum in a model intestinal fermentation system.MethodsSeventy-five hypercholesterolemic men and women were randomly assigned to one of two treatments: 6 grams/day concentrated oat β-glucan or 6 grams/day dextrose (control). Fasting blood samples were collected at baseline, week 3, and week 6 and analyzed for total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides, glucose, insulin, homocysteine and C-reactive protein (CRP). To estimate colonic fermentability, 0.5 g concentrated oat β-glucan was incubated in a batch model intestinal fermentation system, using human fecal inoculum to provide representative microflora. Fecal donors were not involved with the β-glucan feeding trial. Inulin and guar gum were also incubated in separate serum bottles for comparison.ResultsOat β-glucan produced significant reduction from baseline in total cholesterol (-0.3 ± 0.1 mmol/L) and LDL cholesterol (-0.3 ± 0.1 mmol/L), and the reduction in LDL cholesterol were significantly greater than in the control group (p = 0.03). Concentrated oat β-glucan was a fermentable fiber and produced total SCFA and acetate concentrations similar to inulin and guar gum. Concentrated oat β-glucan produced the highest concentrations of butyrate at 4, 8, and 12 hours.ConclusionSix grams concentrated oat β-glucan per day for six weeks significantly reduced total and LDL cholesterol in subjects with elevated cholesterol, and the LDL cholesterol reduction was greater than the change in the control group. Based on a model intestinal fermentation, this oat β-glucan was fermentable, producing higher amounts of butyrate than other fibers. Thus, a practical dose of β-glucan can significantly lower serum lipids in a high-risk population and may improve colon health.

Fructooligosaccharides exhibit more rapid fermentation than long-chain inulin in an in vitro fermentation system

This study investigated how chain length affects fermentation properties of fructooligosaccharides (FOSs) and inulin (IN). Chain lengths of FOSs and IN vary from an average degree of polymerization (DP) of 3 to greater than 20. Three samples classified as FOSs (samples A, B, and C) and 3 samples classified as IN (samples D, E, and F) were fermented via an in vitro batch method with human fecal inoculum as the source of microbes. Samples were removed at 0, 4, 8, 12, and 24 hours for total short-chain fatty acid (SCFA), acetate, propionate, and butyrate measurement via gas chromatography. Sample chain length did not affect SCFA concentrations in a predictable manner. Sample E (90%-94% DP > 10, 6%-10% DP = 1-2), a mixture of long-chain IN and short-chain FOS, produced significantly more total SCFA and acetate than the other samples. Sample F (DP > 20), the longest-chain IN, produced the lowest concentration of butyrate at 24 hours. The rate of FOS fermentation was higher than IN fermentation during 0 to 4 hours for all SCFAs, and the rate of IN fermentation was higher than FOS fermentation during 12 to 24 hours for all SCFAs. Chain length affects in vitro fermentability, with short chains being rapidly fermented and long chains being steadily fermented. Clinical studies should follow this work to verify if these differences exist in vivo.

Evaluation of the Effect of Four Fibers on Laxation, Gastrointestinal Tolerance and Serum Markers in Healthy Humans

Background: Average dietary fiber intake in the United States is roughly half of the recommended amount. As new dietary fiber products are introduced to increase fiber intake, it is critical to evaluate the physiological effects of such fibers. Aims: This study examined the effect of 4 fibers derived from maize or tapioca on fecal chemistry, gastrointestinal (GI) symptoms and serum markers of chronic disease. Methods: Twenty healthy subjects completed the single-blind crossover study in which 12 g/day of fiber (pullulan, Promitor™ Resistant Starch, soluble fiber dextrin or Promitor Soluble Corn Fiber) or placebo (maltodextrin) were consumed for 14 days followed by a 21-day washout. GI symptom surveys were completed (days 3 and 14), stools were collected (days 11–14), diet was recorded (days 12–14) and fasting blood samples were obtained (day 15). Results: The 4 test fibers were well tolerated, with mild to moderate GI symptoms. Total short-chain fatty acid (SCFA) concentrations did not differ among the treatments. Fecal pH and individual SCFAs were affected by some treatments. Stool weight and serum markers of chronic disease did not change with these treatments. Conclusion: Increasing fiber intake by 12 g/day was well tolerated and may have a positive impact on colon health due to fermentation.

Particle size and fraction of wheat bran influence short-chain fatty acid production in vitro

Whole grains are associated with decreased risk of chronic disease and decreased risk of obesity. Several mechanisms may be involved including SCFA production via fibre fermentation in the colon. The aim of the present study was to evaluate the role of wheat bran particle size (large/coarse v. small/fine) and wheat bran fraction (whole bran v. aleurone v. aleurone by-product) in SCFA production using a batch in vitro fermentation system with human faecal inoculum. Five samples were compared: large-particle bran, small-particle bran, aleurone, coarse by-product, fine by-product. Fine by-product produced the greatest SCFA concentrations. By-product (both coarse and fine) produced greater SCFA concentrations than bran (both large and small particle sizes). Aleurone produced SCFA concentrations similar to small-particle bran. The molar percentage of butyrate at 24 h was significantly greater for large-particle bran than the other samples. Small/fine particle size and by-product fraction of bran increased SCFA production compared with large/coarse particle size, and aleurone and whole bran. Bran characteristics and composition should be considered when manufacturing foods due to the diversity of physiological effects.

Wheat Dextrin, Psyllium, and Inulin Produce Distinct Fermentation Patterns, Gas Volumes, and Short-Chain Fatty Acid Profiles In Vitro

Dietary fiber fermentation decreases luminal pH by the production of short-chain fatty acids (SCFAs). Additional proposed physiological benefits of fiber fermentation include decreased growth of pathogenic bacteria, increased mineral absorption, and serving as an energy source for the colon epithelium. This study examined three common fiber supplements--wheat dextrin (WD) (Benefiber, Novartis Consumer Health Inc., Parsippany, NJ, USA), psyllium (PS) (Metamucil, Procter & Gamble, Cincinnati, OH, USA), and inulin (Fiber Sure, Procter & Gamble)--for pH, SCFAs, and gas production. An established in vitro fermentation model was used to simulate colonic fermentation at 0, 4, 8, 12, and 24 hours. At 24 hours, WD and inulin significantly decreased pH compared to PS. Inulin produced significantly more hydrogen and total gas. All treatments produced similar total SCFA concentrations at 24 hours; however, the rate of production was different. PS had a declining rate of SCFA production from 12 to 24 hours, whereas WD and inulin had a higher rate during that period. Fast-fermenting substrates may not provide as much SCFAs to the distal colon as slow-fermenting substrates. Differences in fermentation rate, gas production, and SCFA production observed for WD, PS, and inulin may affect their gastrointestinal tolerance and require further study.

Assessment of dietary fiber fermentation: Effect of Lactobacillus reuteri and reproducibility of short-chain fatty acid concentrations

This investigation had two aims: (i) to determine the reproducibility of SCFA production of two fibers: wheat dextrin and inulin, in two separate in vitro batch fermentation systems, and (ii) to determine if the addition Lactobacillus reuteri, a probiotic bacterium, enhanced the fermentation of wheat dextrin, inulin, and psyllium using in vitro batch fermentation. Samples were removed at 0, 4, 8, 12, and 24 h. SCFAs were measured by GC. L. reuteri improved inulins fermentation profile by reducing the total SCFA peak at 4 h and enhancing fermentation at 8 and 12 h. Wheat dextrin and psyllium were largely unaffected. Wheat dextrins total SCFA and propionate production curves were steady and replicable, but concentration values varied between fermentations. Partially hydrolyzed guar gum (PHGG) and wheat dextrin had similar fermentation patterns from 0-8 h, but PHGG plateaued at 8 h for all measures. Psyllium produced peak SCFA concentrations at 8 h, similar to inulin. L. reuteri could be combined with inulin for enhancing fermentation, but it does not improve wheat dextrin or psyllium fermentation. Wheat dextrin will likely produce similar physiological within a group of individuals due to the reproducibility of fermentation.

Comparison of konjac glucomannan digestibility and fermentability with other dietary fibers in vitro.

Konjac glucomannan (KGM) is a dietary fiber found in Amophophallus konjac. This fiber is fermentable based on human and animal trials, but short-chain fatty acid (SCFA) production profiles are unknown. The aim of this study is to characterize the digestibility and fermentability in vitro of two preparations of KGM, to better understand how KGM improves human health. Konnyaku (yam cake made of A. konjac), isolated KGM, inulin, and guar gum were subjected to in vitro digestion and in vitro fermentation. Fermentation samples were removed at 0, 4, 8, 12, and 24 hours for gas volume, pH, and SCFA measurements. Acetate, propionate, and butyrate were measured with gas chromatography. Results of the in vitro digestion confirm that KGM and konnyaku are resistant to degradation by digestive enzymes. Gas production in fermentation vessels containing konnyaku and KGM was lower than for inulin from 8 to 24 hours. Both samples produced SCFA concentrations similar to guar gum, which favored acetate and propionate over butyrate production. This study is the first to characterize SCFA production by KGM in its isolated form and in food form. Fermentation patterns presented in this study may provide a mechanism for the previously published health benefit of konnyaku and KGM.

Fiber and Microbially Generated Active Components

1. Dietary fiber is a heterogeneous group of compounds consisting of the remnants of plant cells resistant to hydrolysis by human alimentary enzymes.

Fermentation patterns and short chain fatty acid profiles of wheat dextrin and other functional fibres.

Wheat is a major source of fibre in the human diet; the major component being arabinoxylan (AX) which accounts for about 20% and 2% of the dry weight of bran and white flour fractions, respectively. Approximately 25% of the AX in flour is water-soluble, whereas most of that in bran is insoluble. Apart from its intrinsic health benefits, AX, and particularly insoluble AX, also contains high levels of bound phenolic acids (principally ferulic acid) which may have health benefits when released by fermentation in the colon. Work in the HEALTHGRAIN programme has identified substantial variation in the contents of dietary fibre components in wheat genotypes and is determining the genetic control of AX synthesis in order to establish molecular markers for use in plant breeding. Detailed analysis of AX amount and composition across the wheat endosperm has shown the existence of gradients which can be exploited to produce mill streams with defined health benefits.